Immunovant, Inc. Quarterly Common Stock, Value, Issued in USD from Q4 2018 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
Immunovant, Inc. quarterly Common Stock, Value, Issued history and growth rate from Q4 2018 to Q2 2025.
- Immunovant, Inc. Common Stock, Value, Issued for the quarter ending June 30, 2025 was $16K, a 14.3% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)